Potential of liposomes for the treatment of lung cancer- a review

Potential of liposomes for the treatment of lung cancer- a review

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Detalhes bibliográficos
Autor principal:	Mim, Shanzida
Outros Autores:	Sheikh, Zara
Formato:	Tese
Idioma:	English
Publicado em:	Brac University 2023
Assuntos:	Liposome Lung cancer Aerosol formulation Inhalation54 Lung cancer > Treatment
Acesso em linha:	http://hdl.handle.net/10361/21237

Registros relacionados

A review on targeted therapies for lung cancer
por: Ashraf, Anushey
Publicado em: (2023)

A review on recent advances in drugs for lung cancer treatment
por: Noor, Fouzia
Publicado em: (2024)

Molecules associated with the development of lung cancer
por: Rahman, Adree, et al.
Publicado em: (2023)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
por: Rahman, Tasnim
Publicado em: (2024)

Protein biomarkers for Lung Cancer: a bioinformatic approach
por: Jeba, Joynob
Publicado em: (2017)

Comparison of conventional doxorubicin with liposome encapsulated doxorubicin as a treatment of breast cancer-a review
por: Akter, Honufa
Publicado em: (2024)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
por: Pial, Sazia Afrin
Publicado em: (2018)

Immunotherapy in the Management of Lung Cancer
por: Tasnim, Humayra
Publicado em: (2022)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
por: Tania, Umme
Publicado em: (2023)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
por: Zangmo, Thinley
Publicado em: (2024)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
por: Razna, Amrin Islam
Publicado em: (2019)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
por: Hoque, Ismoth Ara
Publicado em: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
por: Flora, Sanzida Alam
Publicado em: (2024)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
por: Shabnam, Musharrat
Publicado em: (2018)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
por: Paul, Pulock
Publicado em: (2024)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
por: Nahar, Kamrun
Publicado em: (2023)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
por: Bristy, Israt Zerin
Publicado em: (2021)

Breast cancer therapy through Liposomal drug delivery system
por: Ome, Nusrat Jahan
Publicado em: (2024)

Lung cancer detection and classification using machine learning
por: Arefin, Mahbubul, et al.
Publicado em: (2023)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
por: Das, Reshita
Publicado em: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
por: Jahan, Nusrat
Publicado em: (2024)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
por: Mukti, Roushney Fatima, et al.
Publicado em: (2016)

Potential phytochemicals and dietary components for the prevention and treatment of skin cancer: A review
por: Muntaha, Habibatul
Publicado em: (2023)

Current practice and approaches of immunotherapy in Cancer treatment
por: Khondokar, Faiza
Publicado em: (2022)

Pulmonary patient compliance among different types of inhaler dosage forms in Mohakhali, Dhaka
por: Rithin, Rafia Islam
Publicado em: (2022)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
por: Nandy, Aditi
Publicado em: (2022)

A review on triple-negative breast cancer and its potential treatment
por: Niasa, Jannatul Ferdous
Publicado em: (2023)

A review on potential of PARP inhibitors in the treatment of prostate cancer
por: Islam, Saidul
Publicado em: (2022)

A comprehensive review on drug repurposing in cancer treatment
por: Sarkar, Onusree
Publicado em: (2024)

Recent advancement on breast cancer detection and treatment
por: Rahman, Sanjida
Publicado em: (2023)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
por: Chakraborty, Anuradha
Publicado em: (2024)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
por: Karim, Samia Binte
Publicado em: (2024)

Biosimilar in lymphoma treatment
por: Tanisha, Mehrin Haque
Publicado em: (2021)

Palliative care services in cancer treatment: a study of the current scenario in Dhaka
por: Rahman, Qazi Ashrafur
Publicado em: (2018)

A review on non-polyphenolic and terpenoid phytoconstituents with antioxidant and cytotoxic potential
por: Ahmed, Kazi Zeba
Publicado em: (2021)

Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
por: Alam, Tahera
Publicado em: (2024)

Targeting BRAFV600E in the treatment of CRC
por: Roja, Mashwiyat Samrin
Publicado em: (2024)

Natural products and their combinatory effects in breast cancer treatment
por: Siddique, Md. Ayman
Publicado em: (2021)

Targeted therapeutic options in the treatment of Breast Cancer
por: Alam, Kazi Tasnuva
Publicado em: (2022)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
por: Hossain, Safa Binte
Publicado em: (2019)